Vascular Solutions Case May Point Way Forward For Off-Label Marketing
Executive Summary
Attorneys involved with a recent court ruling favoring Vascular Solutions believe the verdict might give manufacturers more latitude to engage in truthful, non-misleading, off-label speech. But caution is necessary.
You may also be interested in...
Vascular Solutions Not-Guilty Verdict Another Challenge To FDA Off-Label Oversight
The case against the venous device manufacturer turned on the rights of manufacturers to use truthful off-label speech to promote their products. It joins a growing body of cases in which courts have sanctioned broader off-label speech than has traditionally been allowed by FDA.
Vascular Solutions Alleges Misconduct In Off-Label Case
Attorneys for a device company CEO facing criminal charges for off-label promotional speech are asking for the case be thrown out on grounds of prosecutorial misconduct.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.